Cortexyme Inc

Cortexyme Inc. is a clinical-stage biopharmaceutical company. It is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The company's drug candidate consists of COR388 which is in clinical stage. Cortexyme Inc. is based in San Francisco, United States.

Address Details

Address: 269 EAST GRAND AVE

City: SOUTH SAN FRANCISCO

State: CA

Country: USA

Zip Code: 94080